Bio-Rad Laboratories Inc. Class A Common Stock (BIO)

Stock · NYSE · Industrials

$387.7as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$291.69

Industry

Biotechnology: Laboratory Analytical Instruments

Chosen by industry and closest market cap.

BIO
Bio-Rad Laboratories Inc. Class A Common Stock
$387.7
▼ 0.57%
Market cap $9.16BP/E —
TXG
10x Genomics Inc. Class A Common Stock
$61.55
▼ 5.10%
Market cap $5.79BP/E —
$11.16$66.94
RVTY
Revvity Inc. Common Stock
$128.8
▼ 0.70%
Market cap $12.74BP/E 55.10
$81.22$129.8
ALMR
Alamar Biosciences Inc. Common Stock
$30.71
▼ 6.94%
Market cap $1.95BP/E —
$18.85$38.54
EYPT
EyePoint Inc. Common Stock
$4.47
▼ 3.46%
Market cap $1.08BP/E —
$3.95$19.11
CTKB
Cytek Biosciences Inc. Common Stock
$4.69
▲ 1.41%
Market cap $537.23MP/E —
$3.28$6.18
PACB
Pacific Biosciences of California Inc. Common Stock
$1.4
▼ 10.00%
Market cap $361.85MP/E —
$1.07$2.73

Symbol	Market cap	P/E ratio	Price	1D	52-week range
BIO Bio-Rad Laboratories Inc. Class A Common Stock	$9.16B	—	$387.7	▼ 0.57%
TXG 10x Genomics Inc. Class A Common Stock	$5.79B	—	$61.55	▼ 5.10%	$11.16$66.94
RVTY Revvity Inc. Common Stock	$12.74B	55.10	$128.8	▼ 0.70%	$81.22$129.8
ALMR Alamar Biosciences Inc. Common Stock	$1.95B	—	$30.71	▼ 6.94%	$18.85$38.54
EYPT EyePoint Inc. Common Stock	$1.08B	—	$4.47	▼ 3.46%	$3.95$19.11
CTKB Cytek Biosciences Inc. Common Stock	$537.23M	—	$4.69	▲ 1.41%	$3.28$6.18
PACB Pacific Biosciences of California Inc. Common Stock	$361.85M	—	$1.4	▼ 10.00%	$1.07$2.73

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.